This is a $787,038.78 firm fixed-price delivery order contract awarded by the Bureau of Medicine and Surgery, a component of the U.S. Department of Defense, to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics and medical products. The contract, which has no set-aside designation, provides for the delivery of Roche's medical diagnostic technologies, including laboratory equipment, testing systems, reagents, and clinical testing services, to support...
This is a $89,826.20 firm fixed-price purchase order awarded by the Defense Health Agency to Roche Diagnostics Corporation for benchmark ultra service and maintenance in accordance with the attached performance work statement and pricing schedule. The contract has a period of performance through September 30, 2028 and was awarded on October 1, 2023. This award is not a set-aside contract. Roche Diagnostics is a leading manufacturer and distributor of in vitro diagnostics, reagents, laboratory...
This is a $311,081.10 firm-fixed-price purchase order contract awarded by the Veterans Integrated Service Network 9 of the U.S. Department of Veterans Affairs to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostic products and laboratory instruments. The contract is for the provision of an ANALYZER and has an ultimate completion date of April 19, 2027. The award is not associated with a set-aside program. Roche Diagnostics holds multiple Indefinite...
This federal contract award is for molecular testing equipment, with a ceiling value of $247,811.23. The contract was awarded to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments, on July 11, 2025. The contract is a Blanket Purchase Agreement (BPA) Call with a firm fixed price pricing type. The funding agency is the Defense Health Agency, a defense agency. The contract does not have a set-aside designation,...
This is a firm-fixed-price purchase order awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, and laboratory equipment. The contract, valued at $108,800.00, is for preventative maintenance services to be performed by March 31, 2028. Roche Diagnostics has previously received awards from various federal agencies, including the Department of...
This contract is for the purchase of consumable lab test and quantification material by the Defense Health Agency, a defense agency. The contract was awarded to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, and medical products. The contract has a firm fixed price, ceiling value of $463,109.60, and a period of performance ending on September 23, 2025. No set-aside designation was used. Roche Diagnostics holds multiple significant...
This is a firm fixed-price contract awarded by the Defense Health Agency (DHA) to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The contract, valued at $330,646.79, is for the delivery of controls, reagents, and consumables. This award is a call order under a Blanket Purchase Agreement (BPA) established by DHA, which has a $37 million ceiling and provides immunochemistry and clinical chemistry testing...
This is a firm-fixed-price purchase order awarded by the Veterans Integrated Service Network 6 (VISN 6) of the U.S. Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, laboratory instruments, and medical products. The $88,468.25 contract is for an annual service agreement to provide benchmark ultraperformance liquid chromatography (UPLC) services. The contract does not have a set-aside designation, indicating...
This is a $231,587.80 firm fixed-price definitive contract awarded by the Veterinary Services agency of the U.S. government to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The contract provides base year services and has an ultimate completion date of July 18, 2026. Roche Diagnostics is delivering a range of laboratory equipment, reagents, test kits, and clinical testing services to support multiple federal...
This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostics and medical laboratory equipment. The $223,249.80 contract is for service and maintenance of Roche COBAS 6800 laboratory analyzers over a 5-year period, from June 2022 to June 2027. The contract was awarded without a set-aside designation, indicating Roche Diagnostics competed openly for the requirement. The original...